The International Space Station is the largest space outpost ever built, but it's not the only one up there and there a more ...

With disciplined planning and serious partners, Wallops Island will not just launch rockets. It will anchor Virginia’s next ...

Images like these have become powerful tools for connecting people to the planet, to remind them about the beauty and ...

Hot Jupiters were once cosmic oddities, but unraveling how they moved so close to their stars has remained a stubborn mystery. Scientists have long debated whether these giants were violently flung ...

We're working continuously to improve our search results. If you aren't finding what you expect, please use our feedback form to share the search query and expected result with us so we can improve.

With outstanding customization options, an epic sensor, wireless connectivity, and stunningly lightweight, the Pathfinder is exemplary. Really, it's only mildly let down by its price and the fact that ...

Due to the lapse in federal government funding, NASA is not updating this website. We're working continuously to improve our search results. If you aren't finding what you expect, please use our ...

Describing the latest Russian and Chinese satellite orbital maneuvering as "sophisticated," researchers and analysts are placing greater emphasis on the US developing anti-satellite capabilities—and ...

Aerospace and defense company Inversion is showing off its solution to getting emergency supplies anywhere on Earth in under an hour. It's a constellation of the company's Arc orbital supply craft, ...

INDIANAPOLIS -- Indianapolis Colts backup quarterback Anthony Richardson suffered an orbital fracture to his eye prior to Sunday's 31-27 victory over the Arizona Cardinals, according to coach Shane ...

Oct 10 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...